These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30169584)

  • 1. Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?
    Choi K; Abu-Sbeih H; Samdani R; Nogueras Gonzalez G; Raju GS; Richards DM; Gao J; Subudhi S; Stroehlein J; Wang Y
    Inflamm Bowel Dis; 2019 Jan; 25(2):385-393. PubMed ID: 30169584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis.
    Abu-Sbeih H; Ali FS; Luo W; Qiao W; Raju GS; Wang Y
    J Immunother Cancer; 2018 Sep; 6(1):95. PubMed ID: 30253811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson.
    Wang Y; Abu-Sbeih H; Mao E; Ali N; Ali FS; Qiao W; Lum P; Raju G; Shuttlesworth G; Stroehlein J; Diab A
    J Immunother Cancer; 2018 May; 6(1):37. PubMed ID: 29747688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab.
    Zhang HC; Luo W; Wang Y
    J Immunother Cancer; 2019 Feb; 7(1):47. PubMed ID: 30777137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis.
    Wang Y; Abu-Sbeih H; Mao E; Ali N; Qiao W; Trinh VA; Zobniw C; Johnson DH; Samdani R; Lum P; Shuttlesworth G; Blechacz B; Bresalier R; Miller E; Thirumurthi S; Richards D; Raju G; Stroehlein J; Diab A
    Inflamm Bowel Dis; 2018 Jul; 24(8):1695-1705. PubMed ID: 29718308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.
    Abu-Sbeih H; Herrera LN; Tang T; Altan M; Chaftari AP; Okhuysen PC; Jenq RR; Wang Y
    J Immunother Cancer; 2019 Sep; 7(1):242. PubMed ID: 31488205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis.
    Enwerem NY; Yen EF
    Curr Opin Gastroenterol; 2024 Jan; 40(1):50-59. PubMed ID: 37874119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.
    Wright AP; Piper MS; Bishu S; Stidham RW
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1474-1483. PubMed ID: 31035308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.
    Abu-Sbeih H; Ali FS; Wang X; Mallepally N; Chen E; Altan M; Bresalier RS; Charabaty A; Dadu R; Jazaeri A; Lashner B; Wang Y
    J Immunother Cancer; 2019 Apr; 7(1):93. PubMed ID: 30940209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors.
    Thomas AR; Liu C; Tong YT; Tan D; Altan M; Siddiqui BA; Shatila M; Khan A; Thomas AS; Wang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5429-5436. PubMed ID: 36451045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
    Sato K; Mano T; Iwata A; Toda T
    J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic findings, incidence and characteristics of microscopic colitis in a large cohort of patients from the United Kingdom.
    Kane JS; Rotimi O; Ford AC
    Scand J Gastroenterol; 2017 Sep; 52(9):988-994. PubMed ID: 28562114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases.
    Bonderup OK; Fenger-Grøn M; Wigh T; Pedersen L; Nielsen GL
    Inflamm Bowel Dis; 2014 Oct; 20(10):1702-7. PubMed ID: 25153503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis.
    Kanbay M; Yildiz AB; Siriopol D; Vehbi S; Hasbal NB; Kesgin YE; Celayir M; Selcukbiricik F; Covic A; Perazella MA
    Int Urol Nephrol; 2023 Apr; 55(4):1025-1032. PubMed ID: 36282399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study.
    Shimamura Y; Watanabe S; Maeda T; Abe K; Ogawa Y; Takizawa H
    Clin Exp Nephrol; 2021 May; 25(5):479-487. PubMed ID: 33471239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.
    Abu-Sbeih H; Ali FS; Alsaadi D; Jennings J; Luo W; Gong Z; Richards DM; Charabaty A; Wang Y
    J Immunother Cancer; 2018 Dec; 6(1):142. PubMed ID: 30518410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings.
    Nishida T; Iijima H; Adachi S
    World J Gastrointest Pathophysiol; 2019 Sep; 10(2):17-28. PubMed ID: 31559106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma.
    Yin J; Elias R; Peng L; Levonyak N; Asokan A; Christie A; Kubiliun N; Brugarolas J; Hammers HJ
    Clin Genitourin Cancer; 2022 Jun; 20(3):260-269. PubMed ID: 35277350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical beclometasone dipropionate in the management of immune checkpoint inhibitor-induced microscopic colitis.
    Ibraheim H; Green M; Papa S; Powell N
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30948391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and treatment responses in pediatric lymphocytic and collagenous colitis.
    Narla NP; Smyrk TC; Pardi DS; Tung J
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):557-61. PubMed ID: 23820404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.